Price Chart
Key Statistics
Previous Close
$25.73Day Range
52-Week Range
Avg Volume
68.2KDividend Yield
—Expense Ratio
0.40%AUM
$266.7MShares Outstanding
200.0KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Pharma, Biotech & Life Sciences | 22.34% |
| Capital Goods | 14.85% |
| Consumer Staples Distribution & Retail | 10.20% |
| Software & Services | 8.04% |
| Food Bevg Tobacco | 7.38% |
| Consumer Services | 6.68% |
| Consumer Discretionary | 6.60% |
| Household & Personal Prod | 5.07% |
| Materials | 4.06% |
| Media & Entertainment | 3.58% |
| Health Care Equipment & Services | 3.18% |
| Autos & Components | 2.16% |
| Telecommunications | 1.76% |
| Financial Services | 1.58% |
| Real Estate | 1.51% |
| Transportation | 0.43% |
| Consumer Durables | 0.34% |
| Cash and/or Derivatives | 0.22% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 96.50% |
| United Kingdom | 2.14% |
| Ireland | 1.25% |
| Canada | 0.11% |
Fund Information
- Issuer
- iShares
- Category
- Pharma, Biotech & Life Sciences
- Inception Date
- Sep 21, 2026
- Description
- iShares Future AI Beneficiaries ETF is an exchange-traded fund that seeks to track the Morningstar US Artificial Intelligence Beneficiaries Select Index. The fund invests in U.S. companies that may benefit from the adoption of artificial intelligence, primarily through cost savings and additionally through revenue growth and amplification. The ETF began operations on September 22, 2026 and is listed on NYSE Arca under the ticker AIBF.
Similar ETFs
| Symbol | Name | AUM |
|---|---|---|
| IXJ | iShares Global Healthcare ETF | $4.49B |
The iShares Future AI Beneficiaries ETF (AIBF) is an exchange-traded fund issued by iShares that launched on Sep 21, 2026. It currently manages $266.7M in assets under management. The fund charges an expense ratio of 0.40%. The fund holds 100 securities in its portfolio. It falls under the Pharma, Biotech & Life Sciences category.
Top 10 holdings represent 36.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | WMT | WALMART | 4.56% | 95,753 | $12.1M |
| 2 | COST | COSTCO WHOLESALE CORP | 4.44% | 10,753 | $11.8M |
| 3 | LLY | ELI LILLY | 4.21% | 8,245 | $11.1M |
| 4 | ABBV | ABBVIE | 3.96% | 36,959 | $10.5M |
| 5 | JNJ | JOHNSON & JOHNSON | 3.48% | 34,435 | $9.2M |
| 6 | PG | PROCTER & GAMBLE | 3.43% | 54,118 | $9.1M |
| 7 | KO | COCA-COLA | 3.36% | 92,434 | $8.9M |
| 8 | HD | HOME DEPOT | 3.04% | 23,898 | $8.0M |
| 9 | PANW | PALO ALTO NETWORKS | 3.00% | 21,935 | $7.9M |
| 10 | GE | GE AEROSPACE | 2.92% | 24,223 | $7.7M |
| 11 | MRK | MERCK & CO INC | 2.55% | 50,869 | $6.8M |
| 12 | RTX | RTX | 2.39% | 32,753 | $6.3M |
| 13 | CRWD | CROWDSTRIKE HOLDINGS CLASS A | 2.33% | 25,327 | $6.2M |
| 14 | UNH | UNITEDHEALTH GROUP | 2.31% | 18,464 | $6.1M |
| 15 | LIN | LINDE PLC | 2.14% | 11,079 | $5.7M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.05% | |
| 1W | -3.82% | |
| 1M | -1.63% | |
| 3M | +1.33% | |
| 6M | +1.33% | |
| YTD | +1.33% | |
| 1Y | +1.33% | |
| 3Y | +1.33% | |
| 5Y | +1.33% |
Moving Averages
$26.26
Below 20-Day MA$25.73
Below 50-Day MA$25.73
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$26.80
Current Price
$25.46
52-Week Low
$24.71
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | AIBF | Pharma, Biotech & Life Sciences(2 ETFs) |
|---|---|---|
| Fund Info | ||
| Expense Ratio | 0.40% | 0.39% |
| AUM | $266.7M | $2.38B |
| Dividend Yield | — | 1.26% |
| Avg Volume | 68.2K | 188.8K |
| Holdings | 100 | 105 |
| Performance | ||
| 1-Month Return | -2.25% | -2.13% |
| 6-Month Return | — | +13.47% |
| YTD Return | — | +11.02% |
| 1-Year Return | — | +8.77% |
Compare with Another ETF
Search for an ETF to compare with AIBF:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.